SecBot SecBot
424B4 ·Filed Mar 6, 2026

MMED

MiniMed Group, Inc.
NEUTRAL
Impact 5/10
Horizonimmediate Processed8mo ago SEC0001628280-26-015648
Prospectus supplement
Actionable Insight • Neutral

Monitor whether Medtronic completes the planned divestment of its remaining stake within 180 days, as this could significantly impact stock liquidity and price volatility. Also watch for any changes in the company's relationship with Medtronic, particularly regarding transition services and intellectual property agreements.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$18.00
T+0 close · Mar 6, 2026 · via day close
Latest settled
−31.67%
T+60 · $12.30
Vs SPY
−43.65%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 9 $18.00entry
  2. T+1 · 8mo ago +1.83%α +2.02% · $18.33
  3. T+5 · 8mo ago −11.33%α −9.98% · $15.96
  4. T+20 · 7mo ago −26.67%α −23.86% · $13.20
  5. T+60 · 6mo ago −31.67%α −43.65% · $12.30

Executive Summary

MiniMed Group, Inc. is conducting an initial public offering of 28 million shares at $20.00 per share, raising approximately $538 million in net proceeds. The company, which will remain 90.03% owned by Medtronic post-offering, plans to use the proceeds to retain $350 million in cash for general corporate purposes, repay intercompany debt to Medtronic, and fund future operations. The offering represents the first step in Medtronic's plan to separate its diabetes business into an independent, publicly traded company.

Key Facts

  • Offering 28,000,000 shares at $20.00 per share, raising $560 million in gross proceeds
  • Net proceeds estimated at $538 million after underwriting discounts and expenses
  • Medtronic will retain 90.03% ownership post-offering, making MiniMed a controlled company
  • Proceeds will be used to retain $350 million in cash, repay intercompany debt to Medtronic, and fund operations
  • Company reported $2.7 billion in revenue and $198 million net loss for fiscal year 2025

Financial Impact

Raises $538 million in net proceeds, with $350 million retained as cash on hand

cashdebtdilution

Risk Factors

  • Medtronic may not complete the planned divestment of its remaining stake
  • Company remains dependent on Medtronic for various transition services
  • Recent charge of $118 million related to terminating a manufacturing agreement indicates operational challenges

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B4 Filing (Primary)0001628280-26-015648
Document: 0001628280-26-015648-index-headers.html0001628280-26-015648
Document: 0001628280-26-015648-index.html0001628280-26-015648
Document: 0001628280-26-015648.txt0001628280-26-015648

Track record

25 reports on MMED

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today 8-K Mixed 6/10 Entry $18.77 Now $18.65 −0.64% settles Dec 15
  2. Nov 16, 2026today Press Release Bullish 7/10 Entry $18.81 Now $18.65 −0.86% settles Dec 15
  3. Nov 6, 202610d ago SC 13G Neutral 4/10 Entry $16.71 Now $18.65 +11.61% settles Dec 7
  4. Oct 22, 202625d ago SC 13G Neutral 4/10 Entry $18.34 Now $18.65 +1.69% settles Nov 20
  5. Oct 16, 20264w ago SC 13G/A Neutral 4/10 Entry $17.79 to $18.65 Now $18.65 +4.83% ▲ +4.83% +8.30% vs SPY
  6. Oct 16, 20264w ago 8-K Neutral 6/10 Entry $17.49 to $17.99 Now $18.65 +6.63% ▲ +2.86% +4.02% vs SPY
  7. Oct 6, 20265w ago EFFECT Neutral 3/10 Entry $19.64 to $18.85 Now $18.65 −5.04% ▼ −4.02% −0.85% vs SPY
  8. Oct 1, 20266w ago 3 Neutral 2/10 Entry $19.70 to $18.28 Now $18.65 −5.33% ▼ −7.21% −5.40% vs SPY
  9. Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
  10. Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (11h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 6, 2026